Global Electroporation Instruments Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2023 to 2030

Description

List of Tables

The global demand for Electroporation Instruments Market is presumed to reach the market size of nearly USD 595.98 MN by 2030 from USD 309.85 MN in 2022 with a CAGR of 8.52% under the study period 2023 - 2030.

Electroporation instruments are molecular biology device that uses electrical conductivity to create permeability in the cell membrane, allowing a molecule of interest to pass through it passively. Foreign proteins can be introduced into various cell types, such as bacterial or mammalian cells, using electroporation devices. Electroporation instruments work on the simple principle of combining the host and target molecules in a solution. Electroporation devices are helpful because they allow for transient and transfection in all types of cells and are a quick and straightforward technique that can infect a large number of cells in a short amount of time.

Market Dynamics:

A wide range of end-users uses electroporation instruments. The global electroporation instruments market is primarily driven by growing governmental and private R&D investment. Furthermore, as technological advancements in nanotechnology, biotechnology, and pharmacology increase, the penetration rates of electroporation instruments is expected to rise. Some of the industry's growth drivers include collaboration between leading market participants and academic institutions, financing for electrophoresis technique research, and an increasing focus on next-generation sequencing techniques. However, constraints like strict laws and regulations, a scarcity of experienced professionals, and the high cost of instruments are significant roadblocks to the market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of electroporation instruments. The growth and trends of electroporation instruments industry provide a holistic approach to this study.

Market Segmentation:

This section of the electroporation instruments market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Total Electroporation System
Eukaryotic Electroporation System
Microbial Electroporation System

By Application

Protein Production
Biomedical Research
Therapeutics

By End User

Biotechnology And Pharmaceutical Company
Hospital Laboratories
Academic Research Institutions
Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Electroporation Instruments market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the electroporation instruments market include Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Lonza Group, Harvard Bioscience, Inc. Eppendorf AG., Biotron Healthcare, Sigma-Aldrich Co. LLC. and Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Product Code: VMR11216850

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . ELECTROPORATION INSTRUMENTS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 By Product Type
- 3.7.2 By Application
- 3.7.3 By End User
- 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ELECTROPORATION INSTRUMENTS MARKET ANALYSIS BY PRODUCT TYPE

6.1 Overview by Product Type
6.2 Historical and Forecast Data
6.3 Analysis by Product Type
6.4 Total Electroporation System Market by Regions
6.5 Eukaryotic Electroporation System Market by Regions
6.6 Microbial Electroporation System Market by Regions

7 . GLOBAL ELECTROPORATION INSTRUMENTS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Protein Production Market by Regions
7.5 Biomedical Research Market by Regions
7.6 Therapeutics Market by Regions

8 . GLOBAL ELECTROPORATION INSTRUMENTS MARKET ANALYSIS BY END USER

8.1 Overview by End User
8.2 Historical and Forecast Data
8.3 Analysis by End User
8.4 Biotechnology and Pharmaceutical Company Market by Regions
8.5 Hospital Laboratories Market by Regions
8.6 Academic Research Institutions Market by Regions
8.7 Others Market by Regions

9 . GLOBAL ELECTROPORATION INSTRUMENTS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America
- 9.3.1. Overview, Historic and Forecast Data
- 9.3.2. North America By Segment
- 9.3.3. North America By Country
- 9.3.4. United State
- 9.3.5. Canada
- 9.3.6. Mexico
9.4. Europe
- 9.4.1. Overview, Historic and Forecast Data
- 9.4.2. Europe by Segment
- 9.4.3. Europe by Country
- 9.4.4. United Kingdom
- 9.4.5. France
- 9.4.6. Germany
- 9.4.7. Italy
- 9.4.8. Russia
- 9.4.9. Rest Of Europe
9.5. Asia Pacific
- 9.5.1. Overview, Historic and Forecast Data
- 9.5.2. Asia Pacific by Segment
- 9.5.3. Asia Pacific by Country
- 9.5.4. China
- 9.5.5. India
- 9.5.6. Japan
- 9.5.7. South Korea
- 9.5.8. Australia
- 9.5.9. Rest Of Asia Pacific
9.6. Latin America
- 9.6.1. Overview, Historic and Forecast Data
- 9.6.2. Latin America by Segment
- 9.6.3. Latin America by Country
- 9.6.4. Brazil
- 9.6.5. Argentina
- 9.6.6. Peru
- 9.6.7. Chile
- 9.6.8. Rest of Latin America
9.7. Middle East & Africa
- 9.7.1. Overview, Historic and Forecast Data
- 9.7.2. Middle East & Africa by Segment
- 9.7.3. Middle East & Africa by Country
- 9.7.4. Saudi Arabia
- 9.7.5. UAE
- 9.7.6. Israel
- 9.7.7. South Africa
- 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE ELECTROPORATION INSTRUMENTS COMPANIES

10.1. Electroporation Instruments Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF ELECTROPORATION INSTRUMENTS INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Thermo Fisher Scientific
- 11.3.1. Company Overview
- 11.3.2. Financials
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Bio-Rad Laboratories, Inc.
- 11.4.1. Company Overview
- 11.4.2. Financials
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Lonza Group
- 11.5.1. Company Overview
- 11.5.2. Financials
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Harvard Bioscience, Inc.
- 11.6.1. Company Overview
- 11.6.2. Financials
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Eppendorf AG
- 11.7.1. Company Overview
- 11.7.2. Financials
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Biotron Healthcare
- 11.8.1. Company Overview
- 11.8.2. Financials
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Sigma-Aldrich Co. LLC
- 11.9.1. Company Overview
- 11.9.2. Financials
- 11.9.3. Products
- 11.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies